Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

This article discusses the risk and opportunities of six major constituents of PJP ETF: Pfizer, Amgen, Gilead, AbbVie, BMY, ...

WILMINGTON, DE, UNITED STATES, December 27, 2024 /EINPresswire / -- Global Livestock Parasiticides <a target=_blank href= ...

AbbVie (NYSE: ABBV) recently announced new results from two ongoing clinical trials evaluating epcoritamab, a CD3xCD20 bispecific T-cell-engaging antibody administered subcutaneously, in adult ...

AstraZeneca and Daiichi Sankyo voluntarily withdraw regulatory filing for Dato-DXd in nonsquamous non-small cell lung cancer ...

AstraZeneca PLC (NASDAQ: AZN) – Updated results from the OlympiA Phase III trial showed AstraZeneca and Merck & Co., Inc's, known as MSD outside of the US and Canada, LYNPARZA® (olaparib) demonstrated ...

Amid our daily coverage of the news you need to know, however, a certain kind of story seemed to resonate most with our ...

Merck will encounter some Keytruda-related issues toward the end of the decade, but the company's business and pipeline are ...

Merck will discontinue its antibody-drug Zinplava for a bacterial infection that can lead to fatal diarrhea, according to the ...

New Delhi, Dec 26 (PTI) As technological advancements like AI, machine learning and precision medicine revolutionise drug ...

The FDA is reportedly proposing that cosmetic products containing talc be tested for the presence of asbestos, a known ...

The second and more recent probe involves alleged smuggling of unapproved drugs—the Daiichi-partnered HER2 therapy Enhertu ...